The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $648,073 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to The Johns Hopkins University to conduct the ADHINCRA study, which aims to address hypertension care in Ghana and Nigeria. The project will implement a multilevel intervention that integrates home-based blood pressure monitoring, team-based care with nurse training, and simplified hypertension treatment protocols to improve blood pressure control in...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $585,794 to Tele-Stethoscope Inc., a self-certified small disadvantaged business, to develop a novel mobile phone technology that can detect preeclampsia and hypertension. The key products to be delivered under this award include: Proof-of-concept demonstration that ordinary mobile phones can accurately reproduce a physician's diagnosis of preeclampsia....
This $298,640 Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) aims to develop and pilot a mobile health application called ADEPT (Accessible Diarrhea Etiology Prediction Tool) to support rural healthcare providers in Bangladesh in the management of pediatric diarrhea. The ADEPT app will provide clinical decision support and promote antimicrobial stewardship among these frontline...
This federal Project Grant award of $116,748.00, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to enhance the recipient's capability as a leader in patient-oriented cardiovascular research and mentorship at Washington University. The key products and services to be delivered under this grant include: 1) Conducting new advanced implementation research using the NHLBI-funded Hypertension Treatment in Nigeria...
This Project Grant award of $194,400 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a multilevel implementation intervention to equitably prescribe evidence-based therapy for hospitalized heart failure patients. The key products or services to be delivered through this funding include: Assessing multilevel variation in equitable guideline-directed medical therapy (GDMT) prescribing during...
This $262,627 Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) supports the development and testing of a novel peer navigator mHealth intervention to increase uptake of pre-exposure prophylaxis (PrEP) and modern contraception among female university students in Zambia. The key products and services to be delivered under this grant include: Adapting an existing app, PEBRA, using human-centered design and qualitative methods to create a...
This Project Grant awarded by the Fogarty International Center's International Research and Research Training program (CFDA 93.989) provides $211,347 to the University of Alabama at Birmingham to develop and scale up a consumer-grade wearable monitoring system called CONSOL to improve outcomes in low-resource settings in Ghana. The goal is to enhance the triage of pediatric patients presenting for trauma evaluation in the emergency department and the postoperative vital signs monitoring of...
This $347,386 Project Grant, awarded by the National Science Foundation (NSF) under the Engineering program (CFDA 47.041), aims to develop a novel wearable device for continuous, cuffless blood pressure monitoring. The goal is to create an accurate, inexpensive, and easy-to-use technology to help manage hypertension and reduce hospitalizations associated with this condition. The approach leverages bioimpedance sensing in conjunction with physiological, computational, and machine learning...
This federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support the development of a telemedicine intervention to improve hypertension management for Black patients. The $156,576 award, with a period of performance from September 1, 2024 to August 31, 2029, will be used by the prime awardee, Wake Forest University Health Sciences, to tailor a telemedicine-based hypertension management...
This Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) will support the "SUPPORT YOUR HEART: FEASIBILITY TRIAL OF A CARDIOVASCULAR HEALTH INTERVENTION FOR YOUNG ADULTS" study. The $178,366 award from NIH, with a project period from August 1, 2025 to July 31, 2027, will fund the development and pilot testing of a telephone-based health coaching intervention for young adults to improve their cardiovascular health...